Journal of Pharmaceutical Health Services Research最新文献

{"title":"Expectations regarding prescription renewal and factors associated with them—a nationwide survey of medicine users","authors":"Mirka Korri, Johanna Timonen, Leena Saastamoinen, Emma Aarnio","doi":"10.1093/jphsr/rmaf024","DOIUrl":"https://doi.org/10.1093/jphsr/rmaf024","url":null,"abstract":"Abstract Objectives Users of prescription medicines often require prescription renewal. However, there is very little research on their expectations for renewal. This study aimed to investigate medicine users’ expectations regarding prescription renewal and factors associated with them, as well as channels used to request prescription renewal. Methods The study data were collected through an online survey conducted via Finland’s nationwide electronic healthcare services in October 2021. The associations between respondents’ background variables and expectations regarding prescription renewal were examined using logistic regression analysis. Key findings Of the respondents (n = 1723), 1695 used prescription medicines and were included in the analysis. Of them, 93.7% had expectations regarding prescription renewal. The most common expectation was that the prescription would be renewed as soon as possible (53.0%). Of all respondents, 80.1% had therapeutic expectations regarding renewal. The most frequently reported therapeutic expectation was that the prescriber would establish the respondent’s other medicines and ensure their compatibility before renewal (36.5%). Several factors were associated with therapeutic expectations regarding renewal: gender, certain chronic illnesses, the reported sufficiency of pharmacotherapy monitoring, and experiencing problems with pharmacotherapies. The most frequently used prescription renewal channels were the nationwide patient portal MyKanta (93.6%) and real-time contact with a physician (39.0%). Conclusions Most of the respondents had therapeutic expectations regarding prescription renewal. It is important that these expectations are considered in health care. To meet them, pharmacotherapy monitoring should be an essential part of prescription renewal.","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":"16 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147907448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of Part D Senior Savings Model on healthcare costs among the Medicare population.","authors":"Chi Chun Steve Tsang, Xiangjun Zhang, Ashley Ellis, Junling Wang","doi":"10.1093/jphsr/rmaf017","DOIUrl":"10.1093/jphsr/rmaf017","url":null,"abstract":"<p><strong>Objectives: </strong>The Centers for Medicare and Medicaid Services tested the Part D Senior Savings Model (the 'PDSS Model') from 2021 to 2023, capping insulin cost-sharing at $35/month for Medicare beneficiaries in participating plans. The objective of the study was to assess the PDSS Model's effects on various categories of healthcare costs.</p><p><strong>Methods: </strong>This study analysed the US Medical Expenditure Panel Survey (2020-2021). Study outcomes included costs for insulin, all medications, health services, and overall healthcare. Costs were calculated from patient (out-of-pocket) and healthcare sector perspectives. A difference-in-differences approach was implemented using generalized linear regression to compare cost changes from 2020 to 2021 between Medicare beneficiaries aged 65 and older and near-elderly non-Medicare individuals with private insurance.</p><p><strong>Key findings: </strong>Compared to non-Medicare patients, Medicare beneficiaries in general experienced higher reductions in out-of-pocket costs over time: 29% for insulin (cost ratio [CR] = 0.71, 95% confidence interval [CI] = 0.56-0.90), 66% for health services (CR = 0.34, 95% CI = 0.26-0.44), and 49% for overall healthcare (CR = 0.51, 95% CI = 0.34-0.77). For total costs, Medicare beneficiaries had a 41% smaller increase in insulin costs (CR = 0.59, 95% CI = 0.39-0.90) and a 42% smaller increase in medication costs (CR = 0.58, 95% CI = 0.46-0.74). Medicare beneficiaries experienced a 73% greater increase in total health service costs (CR = 1.73, 95% CI = 1.09-2.77).</p><p><strong>Conclusions: </strong>The PDSS Model was generally associated with reduced out-of-pocket insulin and other out-of-pocket healthcare costs among Medicare beneficiaries, highlighting the value of cost-saving models.</p>","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":"16 3","pages":"rmaf017"},"PeriodicalIF":1.1,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12445858/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145113711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effects of comprehensive medication review on opioid overuse among medicare beneficiaries.","authors":"Yongbo Sim, Clayton F Hausberger, Junling Wang","doi":"10.1093/jphsr/rmae002","DOIUrl":"10.1093/jphsr/rmae002","url":null,"abstract":"<p><strong>Objectives: </strong>This study examined the effects of the comprehensive medication review of Medicare medication therapy management programs on opioid overuse among Medicare beneficiaries.</p><p><strong>Methods: </strong>This retrospective study analyzed Medicare data from 2016 to 2017. The intervention group included Medicare beneficiaries who newly received comprehensive medication review in 2017; the control group referred to patients who met the general eligible criteria for the medication therapy management program but did not enroll in 2016 or 2017. Propensity score matching was performed to increase characteristic compatibility between the intervention and control groups. Three measures of opioid overuse were analyzed: use of opioids at a high dosage, use of opioids from multiple providers, and concurrent use of opioids and benzodiazepines. The effects of comprehensive medication review on opioid overuse were analyzed with a multivariate logistic regression with an interaction term between the receipt of comprehensive medication review and the year 2017.</p><p><strong>Key findings: </strong>The proportion of concurrent use of opioids and benzodiazepines declined at a greater rate among the recipients (2.21%) than non-recipients (1.55%) of the comprehensive medication review. In the adjusted analysis, the odds ratio of no concurrent use of opioids and benzodiazepines was 5% higher (1.05; 95% confidence interval = 1.02-1.09) among recipients than non-recipients. These significant findings were not found for the other two measures of opioid overuse.</p><p><strong>Conclusions: </strong>Comprehensive medication review is associated with reduced concurrent use of opioids and benzodiazepines among Medicare beneficiaries. Such service should be incorporated into the current approaches for addressing the opioid epidemic.</p>","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":"15 1","pages":"rmae002"},"PeriodicalIF":0.5,"publicationDate":"2024-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10901462/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139996548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Measuring the knowledge and perception of Jordanian health science students towards self-prescribed medications: a descriptive analysis study","authors":"R. M. Shudifat, Sultan Mosleh, Suhair Almakhzomi, Mohammad Al Shdifat, Malek Alnajar, Ja’far M Alkhawaldeh, L. Al-Halaseh","doi":"10.1093/jphsr/rmad049","DOIUrl":"https://doi.org/10.1093/jphsr/rmad049","url":null,"abstract":"To assess the level of perception and awareness of health science students towards using over-the-counter (OTC) medicines and reveal any malpractice. A descriptive cross-sectional correlational study employing an internet-based self-administered questionnaire collected data from 342 participants. The study model comprised four compartments: introductory, socio-demographic, utilizing OTC medications, and estimating the perception level. Descriptive statistics were used to describe participants’ demographics and main study variables. Non-parametric descriptive analysis and chi-squared tests were used to determine significance across the three medical schools. The response rate among students in their first academic year (33.9%) was the highest. Most participants rely on OTC to treat minor conditions like pain and the common cold. Nutraceuticals have been used heavily. The participants showed a positive attitude towards self-treatment; the average perception score was 3.45 (SD = 0.60; 95%CI: 3.38–3.51). Besides, participants on regularly prescribed medications still determined the interaction between their treatments and non-prescribed medications. No significant association between attitude average score and participant age (r = −0.06; P = .273). Likewise, no differences were found in perceived attitude towards OTC based on gender (P = .41), academic level (P = .223), and college (P = .84). This study provides an overview of the level of medical student’s perception towards self-treatment; despite the promising levels of knowledge and perception, it is necessitated to introduce interprofessional medical education to get an integrated knowledge and qualified graduates to provide the best health services.","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":"42 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139209947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Community pharmacists’ perception and role in early diagnosis and health promotion of celiac disease","authors":"Rawan Al-Suhaimat, L. Al-Halaseh, A. Al-Samydai","doi":"10.1093/jphsr/rmad048","DOIUrl":"https://doi.org/10.1093/jphsr/rmad048","url":null,"abstract":"The study aims to measure pharmacists’ knowledge and perception of celiac disease. A Google form was used to collect data randomly from 283 pharmacists. The effects of each of the following hypotheses towards early diagnosis of celiac disease and patient compliance were studied: pharmacist’s experience in community pharmacies (H1), pharmacist’s knowledge (H2), pharmacist’s participation in continuing learning programmes (H3), and pharmacist’s attitude and practice (H4). A robust relationship between the variables was confirmed and was expressed by the moderate mean effect of H1, H2, H3, and H4 (2.3332, 2.3386, 2.1731, and 2.5717, respectively, and the correlation coefficient [r] of 0.797). Findings suggest that H1 is moderately correlated with H2 and H3 but weakly correlated with H4 (0.568 and 0.518, 0.183, respectively). Around a third of the participants (33.9%) admit their lack of knowledge regarding the symptoms. A third of the participants would refer the patients with recurrent symptoms to the physician. Three-quarters of the participants (78.4%) have not attended any educational programme, but they show a high desire (84.1%) to participate in such events either in person (50.2%) or through distance learning applications (36.4%). Pharmacists have crucial roles in early diagnosis, monitoring patient compliance, and providing counselling regarding celiac disease. Updating their knowledge should contribute to improving the overall health status of the patients and cutting off the expenses for the health sector.","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":"28 1","pages":""},"PeriodicalIF":0.7,"publicationDate":"2023-11-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139214879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Outcomes of pharmacy facility inspections: implications on pharmaceutical services","authors":"B. Singu, Priscilla Mutsambiwa, Ester Mvula","doi":"10.1093/jphsr/rmad047","DOIUrl":"https://doi.org/10.1093/jphsr/rmad047","url":null,"abstract":"Good Pharmacy Practice (GPP) ensures access to quality medicines, a well-trained and adequate workforce of health professionals, and affordable healthcare. The Namibia Medicines Regulatory Council ensures the sale of medicines and the premises in which such sales are carried out comply with the Medicines and Related Substances Control Act of 2003. The purpose of this study was to report facility inspection outcomes. This was a retrospective review of inspection records archived over a period of 5 years (2017–2021) by the Namibia Medicines Regulatory Council. Compliance by facilities to 13 indicators as stipulated in the Namibia Medicines Regulatory Council inspections checklist adopted from international GPP guidelines was the main measure of outcomes. Results were summarized using descriptive statistics such as median, range, and percentages in R. The Mann–Whitney U test was used to compare medians. General compliance by community pharmacies (operated by pharmacists) was statistically higher (P = .0043) than dispensaries at clinics (mostly operated by nurses) with median (range) values of 84% (30.8–100) and 38% (0.0–100), respectively. There was an improvement in compliance over the 5 years for both pharmacies and clinics. The Ministry of Health & Social Services should implement policies that will ensure appropriately trained pharmaceutical cadres are stationed at all levels of the healthcare system to improve the delivery of pharmaceutical services. In addition, more inspectors need to be recruited for more frequent inspections.","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":"44 2","pages":""},"PeriodicalIF":0.7,"publicationDate":"2023-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139256977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Development and feasibility of an educational module on medication reconciliation for hospital pharmacists in the United Arab Emirates: a pilot study","authors":"Alaa Farajallah, Hadzliana Zainal, Subish Palaian","doi":"10.1093/jphsr/rmad046","DOIUrl":"https://doi.org/10.1093/jphsr/rmad046","url":null,"abstract":"Abstract Background The practice of medication reconciliation by pharmacists is minimal in United Arab Emirates hospitals. Objectives To design an educational module for pharmacists on medication reconciliation and assess its feasibility. Methods The study consisted of three parts: A pre-educational module survey using a validated knowledge, perception, practice, and barriers questionnaire (Cronbach’s α = 0.78), delivery of the educational module, and participants’ feedback. An educational module (general introduction to medication reconciliation, what is medication reconciliation, how to do medication reconciliation, and practicing medication reconciliation) was developed based on Miller’s pyramid and validated by three experts and pilot-tested. The knowledge and perceptions of pharmacists were evaluated by comparing pre-post educational module survey results. Results The module influenced the participants’ knowledge and perception of medication reconciliation. All of the participants gave ‘positive’ feedback on the intervention and the methodology applied, and they agreed on the need for training and workshops related to medication reconciliation. In addition, all ‘agreed’ that a lack of knowledge about medication reconciliation is the biggest barrier to medication reconciliation practices. The results further illustrated that all pharmacists had a ‘positive’ experience and ‘agreed strongly’ on understanding the majority of the content. Conclusion This study was successful in answering the research question by enrolling suitable participants, managing the timeline, and possessing resources for completing the study and hence considered feasible. This module can be utilized in continuous professional development programs to improve pharmacists’ knowledge, perceptions, and practice toward the medication reconciliation process aiming to reduce drug therapy-related problems in hospital settings.","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":" 37","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135291673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Time to treat the climate and nature crisis as one indivisible global health emergency","authors":"Kamran Abbasi, Parveen Ali, Virginia Barbour, Thomas Benfield, Kirsten Bibbins-Domingo, Stephen Hancocks, Richard Horton, Laurie Laybourn-Langton, Robert Mash, Peush Sahni, Wadeia Mohammad Sharief, Paul Yonga, Chris Zielinski","doi":"10.1093/jphsr/rmad045","DOIUrl":"https://doi.org/10.1093/jphsr/rmad045","url":null,"abstract":"","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":"32 7","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135219222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Trends in anti-neuropathic medications turnover in Iraq","authors":"Zainab M Al-Shammaa, Mohammed I Aladul, Narmin S Essa","doi":"10.1093/jphsr/rmad042","DOIUrl":"https://doi.org/10.1093/jphsr/rmad042","url":null,"abstract":"Abstract Objectives Neuropathic pain (NP) is a type of chronic pain. Numerous diseases and/or lesions are associated with the development of NP, and diabetes mellitus is the most prevalent cause. Several classes of medications were recommended and/or approved as anti-neuropathic medications. This study aimed to examine the trends in the turnover of anti-neuropathic medications in Iraq. Methods This was a retrospective analysis of the turnover of selected anti-neuropathic medications in the Iraqi market derived from Advanced Marketing Statistics between 2017 and 2021. The sales units were converted to defined daily doses. Regression analysis and correlation analysis were used to compare the turnover of the medications. Key findings The overall volume of turnover of anti-neuropathic medications increased between 2017 and 2021. The anti-neuropathic market domination was shifted from carbamazepine to pregabalin, in which the average increase in pregabalin turnover of 60% [95% CI (confidence interval) 37.6–82.5] quarterly to achieve 42% of the market share (highest sales) by 2021. The overall expenditure on anti-neuropathic medications increased steadily over the study period. Conclusions The market of anti-neuropathic medications’ domination was shifted from the older antiepileptic drug (AED) (carbamazepine) to the newer AED (pregabalin). The availability and affordability of less expensive generic versions of these agents, together with the better safety profiles of the newer agents were the main driver for this shift. This indeed allowed Iraqi physicians to adhere to the latest international guidelines.","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":"10 3","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135218554","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Awareness and beliefs of community pharmacists on disposal of unused and expired household medications in Indonesia: a cross-sectional study","authors":"Sofa D Alfian, Qisty A Khoiry, Mochammad A A Pratama, Wawan Wahyudin, Irma M Puspitasari, Ivan S Pradipta, Rizky Abdulah","doi":"10.1093/jphsr/rmad043","DOIUrl":"https://doi.org/10.1093/jphsr/rmad043","url":null,"abstract":"Abstract Objective To assess the awareness and beliefs of community pharmacists regarding the disposal of expired and unused household medications in Indonesia. Methods A cross-sectional survey was conducted through convenience sampling. All pharmacists participating in a virtual training event were invited to take part in a self-administer voluntary online survey. A translated and validated questionnaire was used to assess awareness about the harm caused by improper disposal and the beliefs of the best location for collecting expired and unused household medications. Subsequently, demographic data such as age, gender, education level, and work experience of pharmacists were obtained through self-reported data. The characteristics of pharmacists and the outcomes were summarized using descriptive analysis. Correlation analysis was carried out to determine the association between sociodemographic variables and outcomes. Key findings A total of 202 pharmacists completed the survey (response rate: 96.2%). The majority were female (83.2%) and the mean work experience was 4.7 years. Approximately 86% of pharmacists were aware of the environmental harm caused by improper disposing of expired and unused household medications, and 98% acknowledged their role in preventing such risks. Approximately 70%–80% of the respondents believed that community pharmacies were the best location for the collection of expired and unused household medications. No significant associations were found among age, gender, education level, and years of experience and the outcomes. Conclusion Almost all pharmacists were aware of the risk of improper disposal of expired and unused household medications and acknowledged their responsibilities to protect the environment. The strong inclination of pharmacists to select pharmacies as collection points for expired and unused medications strongly advocates for the implementation of medication take-back programs in Indonesia.","PeriodicalId":16705,"journal":{"name":"Journal of Pharmaceutical Health Services Research","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-10-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135779012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}